Day One Biopharmaceuticals, Inc. (DAWN)
SEC fundamentals · as filed in 10-K FY2025, period ended Dec 31, 2025 · updated Oct 7, 2026
as filed in 10-K FY2025, period ended Dec 31, 2025 · View filings on EDGAR ↗
In its 10-K for the period ended Dec 31, 2025, Day One Biopharmaceuticals, Inc. reported revenue of $158.2M, net income of -$107.3M, and total assets of $507.8M. Every figure below is taken directly from Day One Biopharmaceuticals, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2022–FY2025 · as reported
- FY2022 revenue
- $0
- FY2025 revenue
- $158.2M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $158.2M | -$107.3M |
| FY2024 | $131.2M | -$95.5M |
| FY2023 | $0 | -$188.9M |
| FY2022 | $0 | -$142.2M |
| FY2021 | — | -$70.6M |
| FY2020 | — | -$40.5M |
| FY2019 | — | -$12.6M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Apr 23, 2026 | on EDGAR ↗ |
| 10-K/A | Apr 17, 2026 | on EDGAR ↗ |
| 8-K | Mar 6, 2026 | on EDGAR ↗ |
| 8-K | Mar 2, 2026 | on EDGAR ↗ |
| 8-K | Feb 24, 2026 | on EDGAR ↗ |
| 10-K | Feb 24, 2026 | on EDGAR ↗ |
| 8-K | Jan 12, 2026 | on EDGAR ↗ |
| 8-K | Jan 6, 2026 | on EDGAR ↗ |
| 8-K | Nov 24, 2025 | on EDGAR ↗ |
| 8-K | Nov 13, 2025 | on EDGAR ↗ |
Balance Sheet
as of Dec 31, 2025 · 10-K
Income Statement
10-K (annual) · period ended Dec 31, 2025
Per Share & Cash Flow
10-K (annual) · period ended Dec 31, 2025
| EPS (diluted) | $-1.04 | Earnings | source ↗ |
| EPS (basic) | $-1.04 | Earnings | source ↗ |
| Shares Outstanding | 103.3M | Entity | source ↗ |
| Cash from Operations | -$103.8M | Net | source ↗ |
| Cash from Financing | $1.2M | Net | source ↗ |
| Cash from Investing | $174.6M | Net | source ↗ |
Restatement history
Point-in-timeNo material restatements detected across 166 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches DAWN’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/DAWN
MCP tool:
get_sec_fundamentals ticker=DAWN - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/DAWN/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=DAWN as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/DAWN/history
MCP tool:
get_fundamentals_history ticker=DAWN - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/DAWN
MCP tool:
get_financial_health ticker=DAWN
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.